Skip to main content
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
0.00
+0.0490 (1.89%)
Apr 29, 2026, 9:47 AM EDT - Market open

Alaunos Therapeutics Revenue

In the year 2025, Alaunos Therapeutics had annual revenue of $5.00K, down -50.00%. Alaunos Therapeutics had revenue of $3.00K in the quarter ending December 31, 2025, a decrease of -25.00%.

Revenue (ttm)
$5.00K
Revenue Growth
-50.00%
P/S Ratio
1,231.94
Revenue / Employee
$5,000
Employees
1
Market Cap
6.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.00K-5.00K-50.00%
Dec 31, 202410.00K5.00K100.00%
Dec 31, 20235.00K-2.92M-99.83%
Dec 31, 20222.92M2.52M634.17%
Dec 31, 2021398.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Moolec Science 7.83M
Xenetic Biosciences 2.98M
CollPlant Biotechnologies 2.37M
Can-Fite BioPharma 405.00K
BioRestorative Therapies 359.70K
Silo Pharma 72.10K
Ernexa Therapeutics 1,000.00
Revenue Rankings

TCRT News

More News